目的探讨钠钾镁钙葡萄糖注射液补液量对鼻咽癌同步放化疗患者癌因性疲乏、抑郁情绪及耐受性的影响。方法选择我院2012年6月至2015年8月收治的鼻咽癌患者90例作为研究对象,根据随机数字表将入选患者分为观察组(n=47)与对照组(n=43)。两...目的探讨钠钾镁钙葡萄糖注射液补液量对鼻咽癌同步放化疗患者癌因性疲乏、抑郁情绪及耐受性的影响。方法选择我院2012年6月至2015年8月收治的鼻咽癌患者90例作为研究对象,根据随机数字表将入选患者分为观察组(n=47)与对照组(n=43)。两组鼻咽癌患者均同步每周1次顺铂化疗,共7周,顺铂化疗当日补液量均为2500 m L,其中观察组含钠钾镁钙葡萄糖注射液1000 m L,对照组则为常规5%葡萄糖氯化钠注射液。比较两组患者癌因性疲乏(应用CFS量表评估)、抑郁情绪(用SDS量表评估)、耐受性及生活质量(应用QLQ-C30量表评估)。结果观察组化疗1、3、5、7周时的CFS评分均低于对照组,化疗5周及7周时观察组SDS评分均低于对照组,差异有统计学意义(P<0.05)。观察组化疗总中断率为4.3%,低于对照组20.9%,差异有统计学意义(P<0.05)。观察组出院时的功能量表总分与总体健康状况评分均高于对照组,症状量表总分与单项条目总分低于对照组,差异有统计学意义(P<0.05)。结论鼻咽癌同步顺铂化疗进行治疗患者化疗期间补充钠钾镁钙葡萄糖注射液可最大限度改善患者对肿瘤化疗患者癌因性疲乏、抑郁情绪,提高患者耐受性,临床价值显著。展开更多
AIM： To characterize changes in ghrelin levels in response to oral glucose tolerance test （OGTT） and to correlate changes in ghrelin levels with changes in insulin and glucose following OGTT in Chinese obese childr...AIM： To characterize changes in ghrelin levels in response to oral glucose tolerance test （OGTT） and to correlate changes in ghrelin levels with changes in insulin and glucose following OGTT in Chinese obese children of Tanner Ⅰ and Ⅱ stage with insulin resistance. METHODS： 22 obese children with insulin resistance state were divided into four groups according to their Tanner stage and gender： boys of Tanner Ⅰ （fir- Ⅰ ）, boys of Tanner Ⅱ（BT-Ⅱ ）, girls of Tanner Ⅰ （GT- Ⅰ ）, girls of Tanner Ⅱ （GT-Ⅱ）. Ghrelin, insulin and glucose were measured at 0, 30, 60 and 120 rain following OGTT. The control children with normal BMI were divided into control boys of Tanner Ⅰ （CBT- Ⅰ, n = 6）, control boys of Tanner Ⅱ （CBT-Ⅱ, n = 5）, control girls of Tanner Ⅰ （CGT- Ⅰ, n = 6）, control girls of Tanner Ⅱ （CGT-Ⅱ, n = 5）. Fasting serum ghrelin levels were analyzed. RESULTS： Ghrelin levels were lower in obese groups. Ghrelin levels of control group decreased in Tanner Ⅱ stage （CGT- Ⅰ vs CGT-Ⅱ t = -4.703, P = 0.001; CBT- Ⅰ vs CBT- Ⅱ t = -4.794, P = 0.001）. Basal ghrelin levels in fir-Ⅱ decreased more significantly than that in BT- Ⅰ group （t = 2.547, P = 0.029）. Ghrelin levels expressed a downward trend after OGTT among obese children. The decrease in ghrelin levels at 60 min with respect to basal values was 56.9% in BT- Ⅰ. Ghrelin concentrations at 0 min correlated directly with glucose level at 0 min in fir- Ⅰ （r = 0.898, P = 0.015）. There wasn＇t a significant correlation of ghrelin changes with glucose changes and insulin changes during OGTT in obese children with insulin resistance. CONCLUSION： In conclusion, in obese children with insulin resistance, ghrelin levels decreased with advancing pubertal stage. Ghrelin secretion suppression following OGTT was influenced by gender and pubertal stage. Baseline ghrelin levels and ghrelin suppression after OGTT did not significantly correlate with the degree of insulin resistance and insulin sensitivity.展开更多
文摘目的探讨钠钾镁钙葡萄糖注射液补液量对鼻咽癌同步放化疗患者癌因性疲乏、抑郁情绪及耐受性的影响。方法选择我院2012年6月至2015年8月收治的鼻咽癌患者90例作为研究对象,根据随机数字表将入选患者分为观察组(n=47)与对照组(n=43)。两组鼻咽癌患者均同步每周1次顺铂化疗,共7周,顺铂化疗当日补液量均为2500 m L,其中观察组含钠钾镁钙葡萄糖注射液1000 m L,对照组则为常规5%葡萄糖氯化钠注射液。比较两组患者癌因性疲乏(应用CFS量表评估)、抑郁情绪(用SDS量表评估)、耐受性及生活质量(应用QLQ-C30量表评估)。结果观察组化疗1、3、5、7周时的CFS评分均低于对照组,化疗5周及7周时观察组SDS评分均低于对照组,差异有统计学意义(P<0.05)。观察组化疗总中断率为4.3%,低于对照组20.9%,差异有统计学意义(P<0.05)。观察组出院时的功能量表总分与总体健康状况评分均高于对照组,症状量表总分与单项条目总分低于对照组,差异有统计学意义(P<0.05)。结论鼻咽癌同步顺铂化疗进行治疗患者化疗期间补充钠钾镁钙葡萄糖注射液可最大限度改善患者对肿瘤化疗患者癌因性疲乏、抑郁情绪,提高患者耐受性,临床价值显著。
基金Supported by Research Award (2005c24001) from Department of Science and Technology, Zhejiang Province, China
文摘AIM： To characterize changes in ghrelin levels in response to oral glucose tolerance test （OGTT） and to correlate changes in ghrelin levels with changes in insulin and glucose following OGTT in Chinese obese children of Tanner Ⅰ and Ⅱ stage with insulin resistance. METHODS： 22 obese children with insulin resistance state were divided into four groups according to their Tanner stage and gender： boys of Tanner Ⅰ （fir- Ⅰ ）, boys of Tanner Ⅱ（BT-Ⅱ ）, girls of Tanner Ⅰ （GT- Ⅰ ）, girls of Tanner Ⅱ （GT-Ⅱ）. Ghrelin, insulin and glucose were measured at 0, 30, 60 and 120 rain following OGTT. The control children with normal BMI were divided into control boys of Tanner Ⅰ （CBT- Ⅰ, n = 6）, control boys of Tanner Ⅱ （CBT-Ⅱ, n = 5）, control girls of Tanner Ⅰ （CGT- Ⅰ, n = 6）, control girls of Tanner Ⅱ （CGT-Ⅱ, n = 5）. Fasting serum ghrelin levels were analyzed. RESULTS： Ghrelin levels were lower in obese groups. Ghrelin levels of control group decreased in Tanner Ⅱ stage （CGT- Ⅰ vs CGT-Ⅱ t = -4.703, P = 0.001; CBT- Ⅰ vs CBT- Ⅱ t = -4.794, P = 0.001）. Basal ghrelin levels in fir-Ⅱ decreased more significantly than that in BT- Ⅰ group （t = 2.547, P = 0.029）. Ghrelin levels expressed a downward trend after OGTT among obese children. The decrease in ghrelin levels at 60 min with respect to basal values was 56.9% in BT- Ⅰ. Ghrelin concentrations at 0 min correlated directly with glucose level at 0 min in fir- Ⅰ （r = 0.898, P = 0.015）. There wasn＇t a significant correlation of ghrelin changes with glucose changes and insulin changes during OGTT in obese children with insulin resistance. CONCLUSION： In conclusion, in obese children with insulin resistance, ghrelin levels decreased with advancing pubertal stage. Ghrelin secretion suppression following OGTT was influenced by gender and pubertal stage. Baseline ghrelin levels and ghrelin suppression after OGTT did not significantly correlate with the degree of insulin resistance and insulin sensitivity.
